{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:14:24Z","timestamp":1785557664691,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jad.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T08:15:54Z","timestamp":1487060154000},"page":"138-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Maintenance therapy with second generation antipsychotics for bipolar disorder \u2013 A systematic review and meta-analysis"],"prefix":"10.1016","volume":"213","author":[{"given":"Leif","family":"Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"H\u00f6istad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.02.012_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.01.017","article-title":"Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study","volume":"110","author":"Altamura","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.wpsyc.2012.01.006","article-title":"Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients","volume":"11","author":"Baldessarini","year":"2012","journal-title":"World Psychiatry.: Off. J. World Psychiatr. Assoc. (WPA)"},{"issue":"2","key":"10.1016\/j.jad.2017.02.012_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive[HYPHEN]compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2017.02.012_bib4","series-title":"S3-Leitlinie zur Diagnostik und Therapie Bipolarer St\u00f6rungen","author":"Bauer","year":"2012"},{"issue":"Suppl 7","key":"10.1016\/j.jad.2017.02.012_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jad.2017.02.012_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":"Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial","volume":"71","author":"Bowden","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-5618.2011.00974.x","article-title":"Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)","volume":"14","author":"Carlson","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib8","first-page":"f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.jad.2017.02.012_bib9","unstructured":"FDA, 2012. Enrichment strategies for clinical trials to support approval of human drugs and biological products. \u3008www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM332181.pdf\u3009."},{"key":"10.1016\/j.jad.2017.02.012_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry: J. Ment. Sci."},{"issue":"6","key":"10.1016\/j.jad.2017.02.012_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2017.02.012_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The world Federation of Societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry: Off. J. World Fed. Soc. Biol. Psychiatry."},{"key":"10.1016\/j.jad.2017.02.012_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.jad.2017.02.012_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence \u2013 imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.02.012_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.02.012_bib16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence \u2013 inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.02.012_bib17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.02.012_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.02.012_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2017.02.012_bib20","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bdi.12058","article-title":"Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study","volume":"15","author":"Kroon","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":"Long-acting risperidone adjunctive to standard treatment in patients with bipolar disorder who are experiencing mood symptoms","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-5618.2011.00898.x","article-title":"Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study","volume":"13","author":"Marcus","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib26","series-title":"The assessment and management of bipolar disorder in adults, children and young people in primary and secondary care","author":"NICE","year":"2014"},{"key":"10.1016\/j.jad.2017.02.012_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archgenpsychiatry.2011.113","article-title":"Absolute risk of suicide after first hospital contact in mental disorder","volume":"68","author":"Nordentoft","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/eurpub\/ckv245","article-title":"Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987\u20132010","volume":"26","author":"\u00d6sby","year":"2016","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.jad.2017.02.012_bib29","first-page":"92","article-title":"The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline","volume":"110","author":"Pfennig","year":"2013","journal-title":"Dtsch. Arzteblatt Int."},{"key":"10.1016\/j.jad.2017.02.012_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","article-title":"Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder","volume":"68","author":"Quiroz","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/cn5000277","article-title":"Response to lithium in bipolar disorder: clinical and genetic findings","volume":"5","author":"Rybakowski","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jad.2017.02.012_bib32","series-title":"Schizofreni \u2013 l\u00e4kemedelsbehandling, patientens delaktighet och v\u00e5rdens organisation","author":"SBU","year":"2012"},{"key":"10.1016\/j.jad.2017.02.012_bib33","series-title":"Underh\u00e5llsbehandling med nyare antipsykotiska l\u00e4kemedel vid bipol\u00e4r sjukdom","author":"SBU","year":"2015"},{"key":"10.1016\/j.jad.2017.02.012_bib34","series-title":"Utv\u00e4rdering av metoder i h\u00e4lso- och sjukv\u00e5rden. En handbok","author":"SBU","year":"2015"},{"key":"10.1016\/j.jad.2017.02.012_bib35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/0004867415594428","article-title":"A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar disorders Task force on Suicide in Bipolar Disorder","volume":"49","author":"Schaffer","year":"2015","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar 1 disorder: 18-month comparison of olanzapine plus mood stabiliser v mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial","volume":"162","author":"Tohen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euroneuro.2012.03.004","article-title":"A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder","volume":"22","author":"Vieta","year":"2012","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.02.012_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/S1092852900014917","article-title":"The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials","volume":"11","author":"Weisler","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2017.02.012_bib44","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4088\/JCP.11m06878","article-title":"Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (trial 144: a randomized controlled study)","volume":"72","author":"Weisler","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.012_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and International Society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.012_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2012.665177","article-title":"A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder","volume":"15","author":"Young","year":"2014","journal-title":"World J. Biol. Psychiatry.: Off. J. World Fed. Soc. Biol. Psychiatry."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716316251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032716316251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T05:52:07Z","timestamp":1536040327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032716316251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":46,"alternative-id":["S0165032716316251"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.02.012","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maintenance therapy with second generation antipsychotics for bipolar disorder \u2013 A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}